3//SEC Filing
SOFINNOVA VENTURE PARTNERS VI L P 3
Accession 0001209191-10-011578
CIK 0001316175other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:06 PM ET
Size
13.6 KB
Accession
0001209191-10-011578
Insider Transaction Report
Form 3
SOFINNOVA VENTURE PARTNERS VI L P
10% Owner
Holdings
Series B-2 Convertibe Preferred Stock
→ Common Stock (864,855 underlying)Series B-1 Convertible Preferred Stock
→ Common Stock (828,323 underlying)Series A-2 Convertible Preferred Stock
→ Common Stock (384,175 underlying)
Sofinnova Management VI, L.L.C.
10% Owner
Holdings
Series A-2 Convertible Preferred Stock
→ Common Stock (384,175 underlying)Series B-2 Convertibe Preferred Stock
→ Common Stock (864,855 underlying)Series B-1 Convertible Preferred Stock
→ Common Stock (828,323 underlying)
Footnotes (5)
- [F1]The Series A-2 Convertible Preferred Stock is convertible on a one-for-one basis at any time at the holder's election and has no expiration date.
- [F2]Not applicable.
- [F3]Shares are held by Sofinnova Venture Partners VI, L.P. ("SV VI"). Sofinnova Management VI, L.L.C. ("SV VI LLC") is the general partner of SV VI, and James I. Healy, a director of the issuer, Michael F. Powell, Alain L. Azan and Eric P. Buatois, the managing members of SV VI LLC, may be deemed to share voting and dispositive power over the shares held by SV VI. Such persons and entities disclaim beneficial ownership of shares held by SV VI except to the extent of any pecuniary interest therein.
- [F4]The Series B-1 Convertible Preferred Stock is convertible on a one-for-one basis at any time at the holder's election and has no expiration date.
- [F5]The Series B-2 Convertible Preferred Stock is convertible on a one-for-one basis at any time at the holder's election and has no expiration date.
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001211465
Filing Metadata
- Form type
- 3
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 8:06 PM ET
- Size
- 13.6 KB